Canada approves Moderna's Omicron-targeting bivalent for kids, teens

Ottawa, Feb 18 (IANS) Health Canada announced that it has authorized the use of Moderna’s Spikevax bivalent Covid-19 booster vaccine for children and adolescents aged six to 17 years of age targeting the Omicron variant BA.1.

A booster dose of 50 micrograms may be administered in individuals 12 years of age and older at least 4 months after completing their primary vaccine series or a previous booster dose and a booster dose of 25 micrograms in children 6 to 11 years of age at least 6 months after completing their primary vaccine series or a previous booster dose, Xinhua news agency quoted the health body as saying.

“The authorization of a booster dose in children and adolescents is a critical step to broaden protection against the Omicron family of variants, and the emergence of new variants of concern in Canada,” said Stephane Bancel, chief executive officer of Moderna, in a news release.

The BA.1 booster was previously approved for people aged 18 and over.

Moderna’s Omicron-targeting bivalent booster for variant BA.4/5 has not yet been approved for use in people under 18 years of age.

–IANS

ksk/

Agency News Desk
Agency News Deskhttp://glamsham.com
The Agency News Desk comprises team members including Puja T, S Ghadashi, N N Sethi, curate & publish news-worthy domestic & international content from the designated news agencies like Indo Asian News Service, others. The content team can be contacted on editor@glamsham.com and on @glamsham on social media platforms. Kindly visit https://glamsham.com/disclaimer for more information
RELATED ARTICLES

Just In